.@FaisalBakaeen found that follow-up studies of FAME 3 and NOBLE trials utilize highly curated analyses that highlight selected outcomes that favor PCI—ignoring the original primary end points that consistently favored CABG. Read for free in #JTCVS: https://t.co/WtROWmM3VY
"Is a napkin drawing enough?"
What do we actually need from endorobotics?
A room of GI, surgeons, engineers, industry + international faculty (Japan, Korea, China, Saudi Arabia). Sept 24, Cleveland. Half-day before CADEC.
https://t.co/zGV6R3rEXD
@matthew_kroh@cheryl_dimattia@RitaRys1
With an experience of > 32,000 cardiac reoperations @ClevelandClinic and the reality that a patent LITA–LAD graft is “perennial”, we evaluated the risks and outcomes of redo CABG in this challenging context. #JTCVS @aats @CleClinicHVTI https://t.co/S99UeiROPn
Another benefit aside from the lower anastomotic leak rate w Kono-S is that a couple times a year we find an OCCULT CARCINOMA in the final specimen, and if you do extended mesenteric the lymphadenectomy is complete! #HealWithSteel@Johncalvincoffe#IBDSurgery # SoM4Surgery #IBD #Crohn
Very proud to announce #GoLive!!
#PouchTrilogy is live & open for beta testing 🎉 +
🔬 https://t.co/rj0RYP4ZDs — our #IPAA Consortium to
📚 https://t.co/kEHoGM3aHK — AI interface to >10K pouch articles, evidence-based answers
🩺 https://t.co/zNcRgH265Y — same, patient-facing
Enjoyed presenting this truly one-of-a-kind cohort of patients with complete ostial coronary occlusion surviving solely on their bypass grafts. A powerful reminder of what CABG can achieve when nothing else can. Put our paper on your must-read list. #AATS2026
Beyond anecdotal observations, this study documents that in patients with total occlusion of native coronary inflow, survival remains possible—but only with CABG.
Looking forward to #AATS2026
-LBCTs: ART 15yr, COMMENCE 10yr, IMPACT results ++
-New guidance on HIT
-Top CV Journals Fair: @JAMASurgery@JACCJournals@JAMACardio@AATSHQ@annalsthorsurg
-AI for Surgeons
-Presidential Session
- Connecting with legends of our field+future stars
He was a mentor
But departing from evidence, he had my dad w new angina wait 4wks for CABG: Cath/IVUS had shown 70% LM, tight ostial LAD+LCx lesions, RCA occlusion
My beloved dad died before CABG
The ensuing silence left me w #lessons I carry everyday1/
https://t.co/vxkKTIeenh
The inside story that you will not find in textbooks. Three phenomenal surgeon-leaders who changed the way we practice cardiac surgery and established a gold standard in CABG. Floyd Loop MD, Bruce Lytle MD, Toby Cosgrove MD #JTCVS https://t.co/kG8HFXVGxL
An absolute honor to first author select chapters, and then be invited to review this textbook. An outstanding resource for all! A huge thank you to the residents and faculty across the country (and world) who devoted their expertise and time. Congratulations @TSRA_official!
@RakanINazer@NEJM The 3 leaders mastered the surgical technique, meticulously followed their patients clinically and angiographically, sharply observed and analyzed the data, and then pursued maximal impact for the benefit of many.
2) Remarkably,the first 3 authors later went on to serve as Presidents of the @AATSHQ
-Dr. Floyd D. Loop: 78th President
-Dr. Bruce W. Lytle: 87th President
-Dr. Delos M. Cosgrove: 80th President
All 3 were master surgeons. Loop and later Cosgrove became CEOs of @ClevelandClinic